Medicines from the list of medicines at the expense of the Health Insurance Fund of Macedonia (HIFM)
Buyer: General Hospital Struga
- Published
- 10 July 2024
- Submission deadline
- 5 August 2024, 12:00
- Estimated value
- 28,500,000 MKD
- Place of performance
- Strumica, MK004
- Procedure
- Open procedure
- Documents
- 1
- Notice number
- 00410423-2024
- Reference
- 1d39ab38-025b-4f66-9626-a76a5df2bace
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
Description
Medicines from the list of medicines at the expense of the Health Insurance Fund of Macedonia (HIFM)
Lots (151)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | A03BA01-Atropine sol. for inj. 1mg/ml ampoule 3000 | 33600000 Productos farmacéuticos | — |
| 2 | A02BA03- Famotidine powder for sol. for inj. + vehiculum 20 mg piece 21600 | 33600000 Productos farmacéuticos | — |
| 3 | A02BC02 Pantoprazole gastro-resistent tabl. 40 mg tabl. 6720 | 33600000 Productos farmacéuticos | — |
| 4 | A02BC02- Pantoprazole powder for sol. for inj./powder for sol. Inj. or inf. 40 mg piece 4000 | 33600000 Productos farmacéuticos | — |
| 5 | A12AA06 Calcium lactate gluconate sol. for inj. 100 mg/10ml ampoule 2400 | 33600000 Productos farmacéuticos | — |
| 6 | A03BB01 Hyoscine butylbromide sol. for inj. 20mg/1ml ampoule 7200 | 33600000 Productos farmacéuticos | — |
| 7 | A03FA01 Metoclopramide sol. for inj. 10 mg/2ml ampoule 4800 | 33600000 Productos farmacéuticos | — |
| 8 | A04AA01 Ondansetron sol.for inj./inf. 4mg/2ml ampoule 600 | 33600000 Productos farmacéuticos | — |
| 9 | A05BA17 l-Ornithine l-aspartate konc. for sol. for infusion 5g/10ml ampoule 1200 | 33600000 Productos farmacéuticos | — |
| 10 | A10AB05 faster insulin aspart ( Fiasp) sol. for inj. 100IE/ml filled inj. pen 50 | 33600000 Productos farmacéuticos | — |
| 11 | A10AD05 Insulin degludec/ insulin aspar (Ryzodec) sol. for inj. 100 IE /ml filled inj.pen 20 | 33600000 Productos farmacéuticos | — |
| 12 | A10AE06 insulin degludec (Tresiba) sol. for inj. 100 IE /ml filled inj. pen 20 | 33600000 Productos farmacéuticos | — |
| 13 | A10AE56 insulin degludec /liraglutide ( Xultophy) sol. for inj. (100E+3.6mg)ml filled inj.pen 84 | 33600000 Productos farmacéuticos | — |
| 14 | A10BJ06 Semaglutide (Ozempic) sol. for inj. 0.25mg;0.5 mg; 1mg( 2mg/1.5ml;4mg/3ml) filled inj.pen 84 | 33600000 Productos farmacéuticos | — |
| 15 | A10BJ02 Liraglutide ( Saxenda) sol. for inj. 6mg/ml filled pen 120 | 33600000 Productos farmacéuticos | — |
| 16 | A11GA01 Ascorbic acid sol. for inj. 500mg/5ml ampoule 24000 | 33600000 Productos farmacéuticos | — |
| 17 | A11DA01 Thiamine sol. for inj. 100mg/1ml ampoule 12000 | 33600000 Productos farmacéuticos | — |
| 18 | A11HA02 Pyridoxine sol. for inj. 50 mg/2ml ampoule 14400 | 33600000 Productos farmacéuticos | — |
| 19 | B01AB01 Heparin sol. for inj. 25000IE/5ml viala 1200 | 33600000 Productos farmacéuticos | — |
| 20 | B01AB05 Enoxaparin sol. for inj. 4000antiXa IE/0.4ml filled inj. syringe 4800 | 33600000 Productos farmacéuticos | — |
| 21 | B01AB06 Nadroparin solution for injecting 2850antiXaIE/0.3ml filled inj. syringe 2400 | 33600000 Productos farmacéuticos | — |
| 22 | B01AB06 Nadroparin solution for injecting 3800antiXaIE/0.4ml filled inj. syringe 9600 | 33600000 Productos farmacéuticos | — |
| 23 | B01AB06 Nadroparin solution for injecting 5700antiXaIE/0.6ml filled inj. syringe 4800 | 33600000 Productos farmacéuticos | — |
| 24 | B01AC04 Clopidogrel film coated tabl. 75 mg film coated tabl. 10800 | 33600000 Productos farmacéuticos | — |
| 25 | B01AC06 Acetylsalicylic acid gastro-resistant tabl. 100 mg tabl./gastro-resistant tabl. 7200 | 33600000 Productos farmacéuticos | — |
| 26 | B01AC17 Tirofiban conc. for r-r for infusion 0.25mg/1ml viala 50ml 12 | 33600000 Productos farmacéuticos | — |
| 27 | B01AD02 Alteplase powder + vehiculum for solution for inj./infusion 50 mg viala 20 | 33600000 Productos farmacéuticos | — |
| 28 | B02AA02 Tranexemic acid sol. for inj. 500 mg/5ml ampoule 2400 | 33600000 Productos farmacéuticos | — |
| 29 | B02BA01 Phytomenadione sol. for inj. 10mg/ml ampoule 1200 | 33600000 Productos farmacéuticos | — |
| 30 | B03AC02 Saccharated iron oxide sol. for inj. Or conc. for sol for inj.or inf. 100 mg/5ml ampoule 1800 | 33600000 Productos farmacéuticos | — |
Official publications
- TED · 00410423-2024 · 10 July 2024
- OJS · 133/2024 · 10 July 2024
Other tenders from General Hospital Struga
- Održavanje i popravak medicinskih uređaja, ostalih električnih uređaja, elektrodizel generatora, klima uređaja, dizala, aparata za gašenje…
- Medicinski potrošni materijal, medicinska pomagala, šavni materijal, dezinfekcijska sredstva i papir za medicinske uređaje
- Light burning oil - Nafta
- LEKOVI
- Prehrambeni artikli, higijenski proizvodi i jednokratni pribor za jelo
- Reagensi i testovi za hematološke, biokemijske i imunološke pretrage, brzi testovi, vakuumski sustavi za vađenje krvi, plastika, staklo i…
- Light burning oil - Nafta
- Medicinski potrošni materijal, medicinska pomagala, šavni materijal, dezinfekcijska sredstva i papir za medicinske uređaje
- LEKOVI
- Reagensi i testovi za hematološke, biokemijske i imunološke pretrage, brzi testovi, vakuumski sustavi za vađenje krvi, plastika, staklo i…
Frequently asked questions
- What is the deadline to bid for this tender?
- The submission deadline is 5 August 2024, 12:00. Check the official source, as dates can be modified.
- What is the estimated value of this tender?
- The estimated value published by the buyer is 28,500,000 MKD.
- Who is the buyer of this tender?
- The contracting authority is General Hospital Struga (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.